GLP-1 medications like semaglutide and tirzepatide are some of the most effective medicines for diabetes and weight loss. However, getting insurance coverage and paying for it can be a different story. Many people with insurance, whether that’s private insurance, employer-sponsored plans, or government-issued coverage like Medicare and Medicaid, may be asking if they have enough coverage or any coverage at all for GLP-1s.

TL;DR — GLP-1 Insurance (start here)

GLP-1 insurance coverage is highly variable. With so many insurance plans available, coverage for GLP-1s can differ from one plan to another. Plus, policies can quickly change: an insurance company that doesn’t cover GLP-1s today could very well cover them at some point. 

Here are some key general points about insurance coverage for GLP-1s:

• Commercial/employer insurance plans are more likely to cover GLP-1s for type 2 diabetes. For weight management, insurance plans are less likely to cover GLP-1s.
• Plans may require prior authorization (PA) before covering a GLP-1. In other words, a doctor or healthcare provider must send documentation that the medication is medically necessary. 
• Medicare does not generally cover anti-obesity medications for weight loss, though some plans may cover GLP-1s for other related conditions, such as sleep apnea.
• Medicaid may cover GLP-1s for diabetes. However, coverage for GLP-1s for weight loss varies by state. Several states currently cover GLP-1s for weight management. 
• Cash or self-pay programs are available for those without insurance. Manufacturers like Eli Lilly have self-pay programs that cap the prices of certain GLP-1s ($349 to $499 per month for Zepbound vials). Prescription discount cards, patient assistance programs, and other savings options can also be helpful options for those without coverage. 

Coverage may be expanding to allow more people to get access to GLP-1s. Check your insurance plan’s formulary or contact your insurer or pharmacist directly to see if GLP-1s are covered for your condition. 

What counts as a GLP-1—and which brands are covered?

GLP-1 receptor agonists are prescription drugs that mimic a natural hormone the body produces. GLP-1, also known as glucagon-like peptide-1, is often released after a meal to help increase the release of insulin and manage blood sugar levels. It also helps reduce appetite and slow the rate at which food moves through the digestive system. 

There are various GLP-1 agonists approved by the U.S. Food and Drug Administration (FDA). They may be approved under different brand names depending on the indication. These include the following:

• Ozempic (semaglutide): Weekly injection approved for type 2 diabetes, reducing cardiovascular risks in people with heart disease, and reducing the worsening of kidney disease in people with chronic kidney disease.
• Wegovy (semaglutide): Weekly injection approved for obesity or overweight with at least one weight-related condition, reducing cardiovascular risks in people with heart disease, and treating noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH). 
• Rybelsus (semaglutide): Daily oral tablet approved for type 2 diabetes. 
• Mounjaro (tirzepatide): Weekly injection approved for type 2 diabetes.
• Zepbound (tirzepatide): Weekly injection approved for obesity or overweight with at least one weight-related condition and treating obstructive sleep apnea (OSA).
• Byetta (exenatide): Twice-daily injection approved for type 2 diabetes.
• Victoza (liraglutide): Once-daily injection approved for type 2 diabetes and reducing cardiovascular risks in people with heart disease. 
• Saxenda (liraglutide): Once-daily injection approved for obesity or overweight with at least one weight-related condition.

Keep in mind that tirzepatide is a dual GIP/GLP-1 that mimics two hormones that regulate blood sugar and appetite. Studies suggest it can lead to improved blood sugar control and significantly more weight loss than semaglutide. 

Insurance plans may cover GLP-1 medications for their approved uses, although they may have limitations and restrictions. For example, an insurance plan may cover Ozempic for diabetes but not for off-label use for weight loss. Still, for people who might be overweight or obese and have type 2 diabetes, insurance plans may cover the drug if the healthcare provider prescribes it for diabetes. 

Does insurance cover GLP-1s for weight loss?

When it comes to what insurance covers GLP-1s for weight loss, it depends on the insurer. 

Employer and commercial plans

Many employer-sponsored plans cover GLP-1s for weight loss, but they almost always require prior authorization. A healthcare provider may have to describe your specific health condition(s), what treatments you’ve tried, and other factors that would make you a candidate to be covered.

Some employers have recently added GLP-1 coverage, while others have scaled back coverage due to rising costs. Almost 20% of companies with over 200 employees cover GLP-1 drugs for weight loss, with coverage increasing with larger companies. Some surveys show that GLP-1 coverage has become one of the highest costs for employer plans.

On the other hand, around 55% of employer-sponsored plans cover GLP-1s for diabetes, while 36% cover these medications for both diabetes and weight management. The criteria for eligibility for coverage could become stricter, as greater use of GLP-1s could lead to higher premiums. 

Medicare

As of late 2025, Medicare still does not cover anti-obesity medications based on the 2003 Medicare Modernization Act. Medications for cosmetic purposes, erectile dysfunction, and weight gain, among others, have been prohibited from coverage. 

However, the federal government has proposed a new deal in 2026 that would start expanding Medicare and Medicaid coverage for GLP-1 medications (for their approved conditions). 

Medicare Part D covers GLP-1s for diabetes and heart disease. Covered GLP-1s include Ozempic, Mounjaro, and Rybelsus. However, that’s a separate category from weight management, and actual costs could vary by Medicare plan. 

In addition, Medicare plans may have other restrictions, like step therapy and prior authorization. For example, Medicare Advantage plans under Blue Cross Blue Shield and UnitedHealthCare require prior approval for GLP-1s when used for diabetes. 

Medicaid

Medicaid coverage for GLP-1s varies by state. Several states may cover GLP-1s for weight loss, but that may change. Many states are imposing stricter eligibility criteria or discontinuing coverage altogether due to the high costs of GLP-1s.

States that have ended or are ending Medicaid coverage for GLP-1s include:

• North Carolina
• California
• New Hampshire
• South Carolina

Other states may be adding restrictions. For example, Connecticut may allow coverage for state employees, but with specific stipulations, like trying online weight-loss counseling first.  

As with Medicare, the federal government has entered into agreements with Novo Nordisk and Eli Lilly to set price limits for State Medicaid programs. As a result, Medicaid coverage for GLP-1s may be expanding in 2026 to increase access. 

Bottom line: check the drug list, prior authorization policy, and step-therapy notes for your specific plan.

GLP-1 insurance requirements 

Insurance plans generally don’t cover costly drugs like GLP-1s without some form of eligibility criteria. Various factors determine eligibility for GLP-1 insurance coverage. 

Standard criteria for prior authorization

A doctor or healthcare provider may need to describe the following when submitting a prior authorization to your health insurance plan.

• Body mass index (BMI) threshold: Insurance plans ask for documentation on whether you’ve met the BMI threshold, such as a BMI of 30 or over (obesity) or a BMI of 27 or over (overweight), with at least one weight-related condition
• Documented weight-related conditions: Patients who are overweight may be covered if they have at least one weight-related condition like high blood pressure (hypertension), high cholesterol (dyslipidemia), type 2 diabetes, sleep apnea, or heart disease.
• Participation in a weight-loss program: You may need to be part of a nutrition or behavioral program or have documentation of healthy lifestyle changes, such as calorie tracking or exercise.
• The expertise of the healthcare provider: In some cases, insurance plans may require that you be referred to an endocrinologist or an obesity medicine specialist for treatment.
• Re-authorization: If you’re approved for coverage, insurance plans may want to see that you’re making progress with a GLP-1 weight loss with evidence from follow-up visits and adherence after 3 to 6 months.

How to qualify—step-by-step

1. Check your plan’s coverage requirements: First, you’ll want to confirm your plan’s coverage for GLP-1s for weight loss. It can often be as simple as searching your plan’s prior authorization requirements for GLP-1s online. Otherwise, you can contact your insurance company directly.
2. Have the proper documentation: You’ll want to work with your healthcare provider to ensure you have the appropriate documentation to provide to your insurance plan. That could mean having up-to-date BMI values, confirmed diagnoses for comorbid conditions, and other notes on previous weight-loss programs you’ve tried.
3. Enroll in a weight-loss program: If you haven’t already, consider joining a formal program focused on lifestyle changes, such as improved dietary habits, regular exercise, or behavioral modifications. 
4. Make sure your provider has your latest insurance plan info: Your healthcare provider will need to have your latest insurance information, such as whether you have a plan with a company like Kaiser, Cigna, or Horizon. That way, they can get the proper forms to fill out.
5. Wait for a response from the insurance company: Prior authorization can take anywhere from a few days to a few weeks. Your pharmacy or healthcare provider will generally let you know the response, but it doesn’t hurt to follow up.

GLP-1 Insurance Coverage Guide 2026: Costs, Prior Authorization, and How to Get Approved

GLP-1 insurance requirements vary by plan. You have various options and resources to make sure you’re doing everything possible to fulfill your plan’s requirements.

GLP-1 insurance cost (with and without coverage)

If you have insurance, the cost of GLP-1s will depend on different factors, such as:

• Copay tier: Brand-name and specialty drugs are usually on higher tiers, which means higher costs
• Deductibles: If you have a deductible to meet, you might not get coverage until that’s done. Once you’ve met your deductible, your plan may start paying its share of the cost.
• Manufacturer copay cards: These can reduce your copay if a private, commercial plan insures you
• Quantity limits and other restrictions: Insurance plans may limit how much you can get each month or require periodic prior authorizations to make sure the medication is working. 

With commercial insurance, you could pay between $25 and $150, especially with a copay savings card. However, some plans may charge more. 

Without insurance, you could be responsible for the full retail price of the drug, which could be upwards of $1,000 or more. Some manufacturers offer self-pay programs to save on the cash price.

For example, Eli Lilly offers a self-pay program for Zepbound vials, where you can pay $349-$499 per month, depending on the dose. Novo Nordisk has followed suit, lowering its Wegovy prices to $349 per month for cash payers.

Pharmacy discount cards from companies like SingleCare could lower the retail cost at some pharmacies. In addition, patient assistance programs (such as those from the PAN Foundation) may help cover the cost of weight-loss medications. 

If you don’t have insurance coverage, it’s best to explore cash programs. You can then compare them with alternatives such as HSAs/FSAs and discount cards.

No coverage? See today’s self-pay options via our intake.

When insurance says “no”: appeals & alternatives

If you get denied for insurance coverage, that doesn’t mean you’re out of luck. Most, if not all, insurance plans have processes for appealing decisions and potentially getting approved. Follow these steps to address a GLP-1 insurance denial. 

1. See why you were denied: You should receive a denial letter with information about why you were denied, which may include:
   1. Missing documents
   2. Not meeting the criteria
   3. Not having coverage for that drug class
   4. Incorrect coding
2. Follow up with your healthcare provider: Ask whether you can do anything about the denial reasons. For example, if it was denied for missing documentation or not meeting criteria, you could get an updated BMI, evidence for comorbid conditions, or past lab results. 
3. Submit an internal appeal: Most insurance plans require an internal appeal before you can request an external review, if it’s available.
4. Request an external review: States typically allow an external or independent review of the decision. These can sometimes overturn a denial, especially if there’s strong clinical support for the medication.
5. Look at alternatives: If your plan ends up finalizing the denial, you may want to check out other options, such as cash or self-pay programs, telehealth programs, compounded options, and HSAs or FSAs to help cover some of the cost. 

Get help with an appeal—upload your denial letter in our intake.

FAQs (quick answers)

Do any insurances cover GLP-1s for weight loss?

Yes, many employer and commercial plans may cover GLP-1 medications for weight loss, though they may require prior authorization. Medicare typically doesn’t cover weight-loss drugs, though Medicaid coverage varies by state. Coverage will be expanding in 2026. 

What BMI do I need?

The typical BMI threshold for obesity is 30 or higher. Coverage may also be provided to those with a BMI of 27 or over with a weight-related condition, such as high blood pressure or high cholesterol. 

How much will I pay?

The costs of GLP-1 medications with insurance will depend on your plan’s formulary and whether you’ve met your deductible. Without insurance, self-pay programs may charge around $349 to $499 per month for GLP-1s. 

Are Ozempic or Mounjaro covered for weight loss?

These medications aren’t generally covered for weight loss since they’re approved for type 2 diabetes. Insurance may be more likely to cover the brand-name versions approved for weight loss, such as Wegovy and Zepbound. 

Does OSA matter?

Yes, many insurance plans may cover Zepbound for OSA in adults with obesity. However, coverage can vary by plan.